Syneron’s Vela device gives you thinner legs
This article was originally published in The Gray Sheet
Firm gains 510(k) clearance and CE mark certification to market its Vela system for the temporary reduction of thigh circumference. Previously cleared for cellulite treatment, the device simultaneously applies light energy to the tissue at a controlled infrared wavelength, conducted RF energy, and "mechanical manipulations of the skin and fat layer," the company explains. The FDA clearance, announced Aug. 8, was based on a randomized study of 66 patients in the United States and Canada...
You may also be interested in...
Feature: Public Health England has revealed it is only a week away from approving a COVID-19 antibody test for distribution via Amazon. HBW Insight looks at the race to place the first, government-approved coronavirus home-test on the UK market.
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Execs On The Move: New Global Comms Boss At Siemens; CRH CEO Now Also Chair; New CEO At ChroniSense Medical
German multinational firm Siemens picks a global communications head; CRH Medical CEO also takes on chairmanship; ChroniSense Medical, a developer of medical monitoring devices, hires a new CEO; and more.